Gerontological Nursing Certification Examination common mistakes
GERO-BC · Understand the traps and how to avoid them.
Selecting the answer that describes the correct clinical intervention but ignores the setting or scope-of-practice constraint (e.g., recommending an intervention the nurse practitioner cannot order in that setting, or choosing an inpatient action for a home-care scenario).
Candidates focus on disease management content and skim the stem's setting and role cues, then pick the most familiar clinical action rather than the one that fits the practice context.
What to do instead
Before reading the options, underline the setting, the clinician role, and the care phase in the stem. Eliminate any option that requires an authority, resource, or level of care the stem does not establish, even if the intervention is evidence-based.
Treating a single abnormal value or symptom as the trigger for the most aggressive intervention instead of first assessing for a reversible cause, contributing medication, or acute change from baseline.
Exam stems often present a dramatic finding (delirium, a fall, a high glucose) and candidates jump to the treatment of the finding rather than the diagnostic reasoning that should precede it.
What to do instead
For any acute change in an older adult, run a structured first-pass: what changed from baseline, what medications or new illnesses could explain it, and what is the least invasive step that establishes the cause. Choose the assessment or deprescribing step when it appears before the treatment step.
Choosing a medication answer based only on the indication and not screening the proposed drug against the Beers criteria, anticholinergic burden, renal function, or fall risk.
Candidates memorize indications and forget that geriatric pharmacology questions are usually testing harm avoidance, not efficacy. Attractive options are effective drugs that are inappropriate in this population.
What to do instead
For every medication option, ask three questions: is it potentially inappropriate in older adults, does it add to anticholinergic or sedative burden, and is the dose adjusted for renal/hepatic function and weight. Reject effective-but-unsafe options before considering the rest.
Recommending a new medication to treat a symptom that is plausibly a side effect of an existing drug (e.g., adding a hypnotic for insomnia in a patient on a beta-blocker, or an antidepressant for fatigue in a patient on a diuretic).
The prescribing cascade is counterintuitive and candidates default to symptom-to-drug matching rather than drug-to-symptom attribution.
What to do instead
When a new symptom appears, first ask whether a current medication could cause it and whether a trial of dose reduction or discontinuation is the appropriate next step. Prefer the deprescribing option when the stem gives a temporal link between the drug and the symptom.
Selecting a fall-prevention answer that is a single intervention (vitamin D, a bed alarm, a gait belt) rather than a multifactorial assessment and intervention plan.
Candidates recall individual evidence-based components and pick the one they remember best, missing that guideline-concordant care is multifactorial and individualized.
What to do instead
For falls, the correct answer is almost always a multifactorial risk assessment driving a tailored bundle: medication review, vision, footwear, strength and balance exercise, home hazard review, and orthostatic blood pressure. Choose the option that includes assessment plus individualized intervention over any single measure.
Confusing delirium, dementia, and depression and choosing management for the wrong syndrome (e.g., starting an antipsychotic for hypoactive delirium, or attributing acute fluctuating inattention to dementia).
The three conditions overlap in presentation and candidates anchor on the most familiar diagnosis rather than the timeline and attention features.
What to do instead
Anchor on onset and attention: acute onset with fluctuating attention is delirium and the priority is finding and treating the cause plus nonpharmacologic management. Insidious progressive decline is dementia. Apathy and anhedonia with preserved attention point to depression. Choose the option that matches the timeline.
Treating advance care planning as a one-time document (a signed code status or POLST) rather than an ongoing conversation that must be revisited and communicated across settings.
Candidates equate advance care planning with paperwork and pick the option that completes a form rather than the one that confirms goals and transmits them to the care team.
What to do instead
When an advance care planning option appears, prefer the one that involves a goals-of-care conversation with the patient (and surrogate when appropriate), documents the discussion, and ensures the plan travels with the patient across transitions. A form without a conversation is a distractor.
Missing the transition-of-care failure in a scenario: choosing symptom treatment for a post-discharge problem when the real issue is a medication discrepancy, missing follow-up, or absent handoff.
Candidates focus on the presenting complaint and do not scan the scenario for the systems failure that caused it, which is usually the intended teaching point.
What to do instead
In any post-discharge or inter-setting scenario, first look for the discontinuity: reconciled medication list, follow-up appointment, pending test results, and information transfer. If the stem shows a gap, the correct answer usually closes that gap rather than treating the downstream symptom.
Applying a screening or preventive recommendation to an older adult without adjusting for life expectancy, goals, and time-to-benefit (e.g., choosing an intensive cancer screen or tight glycemic target in a patient with limited life expectancy and multimorbidity).
Candidates apply general adult guidelines uniformly and do not weigh competing mortality, burden of treatment, and patient goals.
What to do instead
For prevention and chronic disease targets, ask whether the time to benefit is shorter than the patient's life expectancy and whether the burden of the intervention fits the patient's goals. In multimorbidity with limited life expectancy, prefer individualized, symptom-focused targets and deprescribing over guideline-maximal therapy.
Choosing an intervention that overrides patient autonomy or decision-making capacity without first assessing capacity and confirming the patient's values (e.g., defaulting to family wishes or safety-driven restriction when the patient has capacity).
Candidates conflate 'safe' with 'ethical' and pick the protective option, skipping the capacity assessment and the patient's stated preferences.
What to do instead
When autonomy and safety conflict, first establish whether the patient has decision-making capacity and what their values are. If capacity is intact, the patient's informed choice prevails over family or clinician preference; if capacity is impaired, use the appropriate surrogate and standards. Choose the option that reflects that sequence.